What Makes Retatrutide Different?Triple action: Unlike semaglutide (GLP-1 only) or tirzepatide (GLP-1 + GIP), retatrutide works on GLP-1, GIP, and glucagon receptors.
Appetite suppression & delayed gastric emptying: Patients feel full for longer, naturally cutting calorie intake.
Blood sugar regulation: Helps lower HbA1c while promoting weight loss.
Weekly dosing: Like Kilimanjaro, it’s injected once per week.
The Godzilla Numbers24.2% average weight loss in 48 weeks (about 58 pounds)
Nearly half of patients lost over 25% of their body weight in trials
Results rival bariatric surgery outcomes, something no previous drug has been able to claim
One researcher even compared the current market leaders, saying:
“Tirzepatide is the King Kong of GLP-1s... Retatrutide is Godzilla smiling.”
Side Effects & ConsiderationsMostly GI-related: nausea, diarrhea, constipation, similar to other GLP-1 drugs.
Some increased heart rate noticed, which subsided after 24 weeks.
Still in clinical trials — not yet widely available.
Why the Buzz?If approved, retatrutide could become the benchmark therapy for obesity.
Media outlets are calling it “the next Godzilla” because it crushes previous contenders in terms of efficacy.
The demand for GLP-1s is already overwhelming (Ozempic, Wegovy, Kilimanjaro shortages). Adding a “Godzilla-level” drug into the mix could reshape the entire market.
Community Question:Do you think Retatrutide will dethrone Kilimanjaro as the most powerful weight loss injection, or will cost and accessibility keep “Godzilla” in its cage for now?
Would you trust it over bariatric surgery if the results hold up in Phase 3?
Direct Links:
Website: https://sveltalabs.com
WhatsApp: http://wa.me/447880901104 Telegram: https://t.me/Svelta Labs